CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Clinical Trials Imaging Market Size, Trends, Analysis, and Outlook By Service and Software (Services, Software), By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, Echocardiography), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, CVS, Endocrinology, Immunological Disorder), By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic and Government Research Institutes), by Country, Segment, and Companies, 2024-2032
... CVS, Endocrinology, Immunological Disorder), By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic and Government Research Institutes), by Country, Segment, and Companies, 2024-2032 The global Clinical Trials Imaging market size is ... Read More
-
Small Molecule Drug Discovery Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others), By Process (Target ID/Validation, Hit Generation and Selection, Lead Identification, Lead Optimization), by Country, Segment, and Companies, 2024-2032
... by Country, Segment, and Companies, 2024-2032 The global Small Molecule Drug Discovery market size is poised to register 8.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Synthetic Stem Cells Market Size, Trends, Analysis, and Outlook By Application (Cardiovascular Disease, Neurological Disorders, Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders), By End-User (Hospitals and surgical centers, Academic institutes, Research laboratories, Pharmaceutical and biotechnology companies, Others), by Country, Segment, and Companies, 2024-2032
... by Country, Segment, and Companies, 2024-2032 The global Synthetic Stem Cells market size is poised to register 23.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Schizophrenia Market Report and Forecast 2024-2032
... along with heightened awareness surrounding mental health disorders across the 8 major markets. The market is expected to grow at a CAGR of 5.80% during the forecast period of 2024-2032, with the values likely to ... Read More
-
Nuclear Medicine Market Size, Trends, Analysis, and Outlook By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032
... By End-User (Hospitals & Clinics, Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032 The global Nuclear Medicine market size is poised to register 12.4% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
2024 Global Residential Mental Retardation Facilities Industry Report (2025-2030 Outlook)
... Sharpe Research) The Global Industry Outlook reports provide industry size and growth data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Industry ... Read More
-
Global Medical Imaging Reagents Market Size study & Forecast, by Modality (X-ray, CT scan, Ultrasound, MRI Scan), by Class (Contrast Reagent, Optical Reagent, Nuclear Reagent), by Application (Neurological Disorder, Cardiovascular Disorder, Cancer, Gastrointestinal Disorder, Musculoskeletal Disorder, Nephrological Disorder, Others) and Regional Analysis, 2023-2030
... Disorder, Nephrological Disorder, Others) and Regional Analysis, 2023-2030 Global Medical Imaging Reagents Market is valued at approximately USD 16 billion in 2022 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2024-2032
... global glioblastoma multiforme treatment market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2024-2032
... Region 2024-2032 The global RNA interference (RNAi) drug delivery market size reached US$ 84.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 410.3 Billion by 2032, exhibiting a growth rate ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type (Sporadic ALS, Familial ALS), Drug Type (Marketed Drugs, Emerging Drugs), Diagnosis Type (Electromyogram, MRI, Blood and Urine Tests, Spinal Tap, Muscle Biopsy), Treatment (Medication, Stem Cell Therapy, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... Therapy, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global amyotrophic lateral sclerosis treatment market size reached US$ 754.4 Million in 2023. Looking forward, IMARC Group expects the market ... Read More
-
Single Cell Multiomics Market Report by Type (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics), Product Type (Consumables, Instruments, Software), Technique (Single-Cell Isolation and Dispensing, Single-Cell Analysis), Application (Oncology, Cell Biology, Neurology, and Others), End User (Academic Institutes, Contract Research Organizations, Pharmaceutical and Biotech Companies), and Region 2024-2032
... Neurology, and Others), End User (Academic Institutes, Contract Research Organizations, Pharmaceutical and Biotech Companies), and Region 2024-2032 The global single cell multiomics market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects ... Read More
-
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type (Autologous Stem Cells, Autologous Non-Stem Cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, Research Facilities), and Region 2024-2032
... Facilities), and Region 2024-2032 The global autologous stem cell and non-stem cell based therapies market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.6 Billion by ... Read More
-
Psychedelics Therapeutics Development and Trends, 2024
... including regulatory, clinical, and market dynamics. The report identifies the broader changes within the evolving psychedelic industry, facilitating informed decision-making for relevant sectors. Scope This 36-page report gives important, expert insight you won’t find in ... Read More
-
IVD in Cardiology and Neurology Market – By Product Type (Instruments, Reagents, Kits & Consumables, Software & Services), Technology (Immunoassays, Molecular Diagnostics, Hematology), End-use (Hospitals, Clinics) – Global Forecast (2024 - 2032)
... and neurology market size is projected to record 5% CAGR between 2024 and 2032, driven by the rising prevalence of cardiovascular and neurological diseases. As per WHO, cardiovascular diseases (CVDs) are the major cause of ... Read More
-
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Anorexia Nervosa - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Equine encephalitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Glioblastoma- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Glioblastoma: Understanding Glioblastoma: Overview ... Read More
-
5-HT1 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Personalized Medicine Market Report by Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics, Personalized Medical Care, and Personalized Nutrition and Wellness), Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, and Others), End-Users (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), Region and Company Analysis 2024-2032
... & Academic Institutes, and Others), Region and Company Analysis 2024-2032 The global personalized medicine market was worth US$ 511.09 billion in 2023 and is expected to grow at a CAGR of 7.02% from 2024 to ... Read More
-
Obese patients with Schizophrenia - Pipeline Insight, 2024
... the Obese patients with Schizophrenia market. A detailed picture of the Obese patients with Schizophrenia pipeline landscape is provided, which includes the disease overview and Obese patients with Schizophrenia treatment guidelines. The assessment part of ... Read More
-
Acute Social Anxiety Disorder - Pipeline Insight, 2024
... the Acute Social Anxiety Disorder market. A detailed picture of the Acute Social Anxiety Disorder pipeline landscape is provided, which includes the disease overview and Acute Social Anxiety Disorder treatment guidelines. The assessment part of ... Read More
-
2024 Global Cognitive Assessment And Training Market Industry (2030 Outlook)
... Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product ... Read More
-
Autism - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Autism treatment guidelines. The assessment part of the report embraces in-depth Autism commercial assessment and clinical assessment of the Autism pipeline products from the pre-clinical ... Read More
Research Assistance
